Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Propanc Biopharma Inc (PPCB) had Return on Investments of -33.69% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-4.84M |
|
-- |
|
-- |
|
$4.67M |
|
$-4.67M |
|
$-0.16M |
|
$-4.84M |
|
$-4.84M |
|
$-4.84M |
|
$-4.84M |
|
$-4.84M |
|
$-4.84M |
|
$-4.67M |
|
$-4.67M |
|
12.33M |
|
12.33M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$8.76M |
|
$0.00M |
|
$9.21M |
|
$17.98M |
|
$3.57M |
|
-- |
|
$0.04M |
|
$3.61M |
|
$14.36M |
|
$14.36M |
|
$14.36M |
|
12.81M |
|
| Cash Flow Statement Financials | |
$-1.94M |
|
$-0.00M |
|
$2.53M |
|
$0.01M |
|
$0.60M |
|
$0.59M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.45 |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.69% |
|
-33.69% |
|
-26.91% |
|
|
Return on Investments |
-33.69% |
$1.12 |
|
$-0.16 |
|
$-0.16 |
|